Pacira | PCRX - 贷款资金

金融业

USD

USD 1.21B

现金及等价物

USD 144.31M

USD 50.74M

USD 514.96M

USD 108.79M

USD 367.66M

USD 4.63M

USD 40.24M

790

EPS每股收益

USD 0.6

股本和储备

USD 653.89M

USD 126.64M

债务利息支出

USD 3.7M

USD 2.3M

USD 367.66M

USD 1.05B

USD 2.92M

USD 172.75M

USD 4.63M

普通股股本

USD 39.31M

38.58

USD 571K

USD 177M

销售和管理费用

USD 83.88M

USD 150.37M

贸易债权人

USD 14.01M

应收帐款人

USD 125.64M

	贷款资金	更改		日
Assertio Holdings	USD 39.17M		120K	2025-09
Astellas Pharma	JPY 320B		0	2026-03
Bristol-Myers Squibb	USD 42.15B		698M	2026-03
Cara Therapeutics	USD 0		0	2025-03
Coherus Biosciences	USD 51.08M		496K	2025-12
Heron Therapeutics	USD 140.64M		975K	2025-12
Ironwood Pharmaceuticals	USD 583.99M		14.83M	2024-12
J&J	USD 37.53B		1.91B	2026-03
Ligand Pharmaceuticals	USD 446.19M		702K	2025-12
Nektar Therapeutics	USD 63.16M		44.35M	2025-12
Novo Nordisk	DKK 119.17B		231M	2026-03
Omeros	USD 403.72M		27.2M	2024-06
Pacira	USD 367.66M		4.53M	2026-03
Perrigo	USD 3.62B		17.5M	2026-03
Pfizer	USD 60.57B		1.08B	2026-03
Supernus Pharmaceuticals	USD 400.38M		21.13M	2022-03
Teva Pharmaceutical Industries	USD 14.02B		971M	2026-03
Xeris Pharmaceuticals	USD 221.22M		889K	2026-03
Xoma	USD 94.38M		7.82M	2025-09
Zoetis	USD 9.04B		3M	2026-03